Annual Retained Earnings:
-$1.43B-$463.66M(-47.92%)Summary
- As of today, RXRX annual retained earnings is -$1.43 billion, with the most recent change of -$463.66 million (-47.92%) on December 31, 2024.
 - During the last 3 years, RXRX annual retained earnings has fallen by -$1.03 billion (-257.75%).
 - RXRX annual retained earnings is now -1030.60% below its all-time high of -$126.59 million, reached on December 31, 2019.
 
Performance
RXRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$1.81B-$171.90M(-10.52%)Summary
- As of today, RXRX quarterly retained earnings is -$1.81 billion, with the most recent change of -$171.90 million (-10.52%) on June 30, 2025.
 - Over the past year, RXRX quarterly retained earnings has dropped by -$649.05 million (-56.12%).
 - RXRX quarterly retained earnings is now -745.31% below its all-time high of -$213.60 million, reached on December 1, 2020.
 
Performance
RXRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RXRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | 
|---|---|---|
| 1Y1 Year | -47.9% | -56.1% | 
| 3Y3 Years | -257.8% | -246.2% | 
| 5Y5 Years | -1030.6% | - | 
RXRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -257.8% | at low | -210.2% | at low | 
| 5Y | 5-Year | -1030.6% | at low | -745.3% | at low | 
| All-Time | All-Time | -1030.6% | at low | -745.3% | at low | 
RXRX Retained Earnings History
| Date | Annual | Quarterly | 
|---|---|---|
| Jun 2025 | -  | -$1.81B(-10.5%)  | 
| Mar 2025 | -  | -$1.63B(-14.1%)  | 
| Dec 2024 | -$1.43B(-47.9%)  | -$1.43B(-14.3%)  | 
| Sep 2024 | -  | -$1.25B(-8.3%)  | 
| Jun 2024 | -  | -$1.16B(-9.2%)  | 
| Mar 2024 | -  | -$1.06B(-9.4%)  | 
| Dec 2023 | -$967.62M(-51.3%)  | -$967.62M(-10.6%)  | 
| Sep 2023 | -  | -$874.63M(-11.9%)  | 
| Jun 2023 | -  | -$781.61M(-10.9%)  | 
| Mar 2023 | -  | -$704.88M(-10.2%)  | 
| Date | Annual | Quarterly | 
|---|---|---|
| Dec 2022 | -$639.56M(-59.9%)  | -$639.56M(-9.9%)  | 
| Sep 2022 | -  | -$582.06M(-11.6%)  | 
| Jun 2022 | -  | -$521.62M(-14.4%)  | 
| Mar 2022 | -  | -$456.06M(-14.0%)  | 
| Dec 2021 | -$400.08M(-87.3%)  | -$400.08M(-19.4%)  | 
| Sep 2021 | -  | -$335.15M(-16.5%)  | 
| Jun 2021 | -  | -$287.72M(-17.8%)  | 
| Mar 2021 | -  | -$244.32M(-14.4%)  | 
| Dec 2020 | -$213.60M(-68.7%)  | -  | 
| Dec 2020 | -  | -$213.60M  | 
| Dec 2019 | -$126.59M  | -  | 
FAQ
- What is Recursion Pharmaceuticals, Inc. annual retained earnings?
 - What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?
 - What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?
 - What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?
 - What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?
 - What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
 
What is Recursion Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of RXRX is -$1.43B
What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual retained earnings is -$126.59M
What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, RXRX annual retained earnings has changed by -$463.66M (-47.92%)
What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of RXRX is -$1.81B
What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$213.60M
What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, RXRX quarterly retained earnings has changed by -$649.05M (-56.12%)